Loading...
Market
What will be the percentage increase in successful glioma surgeries attributed to FastGlioma by end of 2025?
2
Resolution / Starting Odds
Less than 5% • 25%
5% to 10% • 25%
10% to 20% • 25%
More than 20% • 25%
Published medical reports and surgical outcomes studies
Story
AI Tool FastGlioma Detects Brain Tumors in Seconds with 92% Accuracy During Surgery
Nov 14, 2024, 07:51 AM
Researchers at the University of Michigan (UMich) and UCSF have developed an AI tool called FastGlioma that can detect brain tumor boundaries in real-time during surgery with 92% accuracy. This innovative technology identifies remaining brain tumor tissue in just 10 seconds, significantly outperforming traditional methods that miss nearly 25% of residual tumors. The AI model, validated in a prospective multi-center trial and made open-source, provides a visual foundation for intraoperative brain surgery, enabling accurate detection of glioma infiltration without the need for labels. Published in Nature and validated by ToddCHollon, this breakthrough addresses a critical challenge in glioma treatment, offering real-time guidance to surgeons and potentially improving surgical outcomes.
View original story
Similar markets
Less than 50% • 25%
50% to 74% • 25%
75% to 80% • 25%
More than 80% • 25%
New drug approval • 25%
Major clinical trial success • 25%
New treatment guidelines • 25%
Other • 25%
Less than 10% • 33%
10% to 25% • 33%
More than 25% • 33%
Yes • 50%
No • 50%
Less than 5% • 25%
5% - 10% • 25%
11% - 15% • 25%
More than 15% • 25%
Less than 10% • 25%
10%-25% • 25%
25%-50% • 25%
More than 50% • 25%
0-10% • 25%
11-25% • 25%
26-50% • 25%
51%+ • 25%
0-10% • 25%
11-20% • 25%
21-30% • 25%
31% or more • 25%
Less than 20% • 25%
20-40% • 25%
40-60% • 25%
More than 60% • 25%
0-10% • 25%
11-20% • 25%
21-30% • 25%
Over 30% • 25%
0-25% • 25%
26-50% • 25%
51-75% • 25%
76-100% • 25%
Successful Phase I trial • 25%
FDA Fast Track designation • 25%
Publication of promising preclinical results • 25%
No major milestone achieved • 25%